CHAMPIONS ONCOLOGY, INC. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q4 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Champions Oncology, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q4 2024.
  • Champions Oncology, Inc. Entity Common Stock, Shares Outstanding for the quarter ending December 13, 2024 was 13.8M shares, a 1.66% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 13.8M +225K +1.66% Dec 13, 2024 10-Q 2024-12-16
Q3 2024 13.6M +115K +0.85% Sep 10, 2024 10-Q 2024-09-13
Q2 2024 13.6M +134K +1% Jul 18, 2024 10-K 2024-07-19
Q1 2024 13.6M +35.1K +0.26% Mar 8, 2024 10-Q 2024-03-15
Q4 2023 13.6M +35.1K +0.26% Dec 8, 2023 10-Q 2023-12-13
Q3 2023 13.5M -43.2K -0.32% Sep 8, 2023 10-Q 2023-09-13
Q2 2023 13.5M -62.9K -0.47% Jul 18, 2023 10-K 2023-07-24
Q1 2023 13.6M +36.2K +0.27% Mar 15, 2023 10-Q 2023-03-16
Q4 2022 13.6M +43.8K +0.32% Dec 9, 2022 10-Q 2022-12-13
Q3 2022 13.5M +100K +0.75% Sep 9, 2022 10-Q 2022-09-12
Q2 2022 13.5M +107K +0.8% Jul 20, 2022 10-K 2022-07-22
Q1 2022 13.5M +132K +0.99% Mar 11, 2022 10-Q 2022-03-15
Q4 2021 13.5M +146K +1.09% Dec 10, 2021 10-Q 2021-12-13
Q3 2021 13.4M +694K +5.45% Sep 10, 2021 10-Q 2021-09-13
Q2 2021 13.4M -12.7T Jul 16, 2021 10-K 2021-07-26
Q1 2021 13.4M +1.5M +12.6% Mar 5, 2021 10-Q 2021-03-15
Q4 2020 13.4M +1.75M +15.1% Dec 4, 2020 10-Q 2020-12-14
Q3 2020 12.7M +1.11M +9.54% Sep 4, 2020 10-Q 2020-09-14
Q2 2020 12.7T* +12.7T Jul 17, 2020 10-K 2020-07-28
Q1 2020 11.9M +272K +2.35% Mar 6, 2020 10-Q 2020-03-16
Q4 2019 11.6M +456K +4.08% Dec 6, 2019 10-Q 2019-12-16
Q3 2019 11.6M +455K +4.08% Sep 11, 2019 10-Q 2019-09-16
Q2 2019 11.6M +594K +5.39% Jul 15, 2019 10-K 2019-07-29
Q1 2019 11.6M +614K +5.59% Mar 14, 2019 10-Q 2019-03-18
Q4 2018 11.2M +176K +1.6% Dec 12, 2018 10-Q 2018-12-17
Q3 2018 11.2M +178K +1.63% Sep 7, 2018 10-Q 2018-09-14
Q2 2018 11M +43.5K +0.4% Jul 13, 2018 10-K 2018-07-30
Q1 2018 11M +22.5K +0.21% Mar 16, 2018 10-Q 2018-03-19
Q4 2017 11M +20.9K +0.19% Dec 9, 2017 10-Q 2017-12-15
Q3 2017 11M +18.5K +0.17% Sep 9, 2017 10-Q 2017-09-14
Q2 2017 11M -255K -2.27% Jul 15, 2017 10-K 2017-07-28
Q1 2017 11M +2.28M +26.2% Mar 17, 2017 10-Q 2017-03-17
Q4 2016 11M +2.27M +26% Dec 9, 2016 10-Q 2016-12-14
Q3 2016 11M +2.27M +26% Sep 9, 2016 10-Q 2016-09-14
Q2 2016 11.2M -93.2M -89.2% Jul 15, 2016 10-K 2016-07-29
Q1 2016 8.7M -95.3M -91.6% Mar 11, 2016 10-Q 2016-03-16
Q4 2015 8.7M -58.2M -87% Dec 11, 2015 10-Q 2015-12-15
Q3 2015 8.7M -58.2M -87% Aug 31, 2015 10-Q 2015-09-11
Q2 2015 104M +37.5M +56.1% Jul 15, 2015 10-K 2015-07-29
Q1 2015 104M +37.2M +55.6% Mar 13, 2015 10-Q 2015-03-17
Q4 2014 66.9M +22.5K +0.03% Nov 30, 2014 10-Q 2014-12-15
Q3 2014 66.9M +33.6K +0.05% Aug 31, 2014 10-Q 2014-09-12
Q2 2014 66.9M +33.6K +0.05% Jun 30, 2014 10-K 2014-07-28
Q1 2014 66.9M +115K +0.17% Feb 28, 2014 10-Q 2014-03-14
Q4 2013 66.9M +19.8M +42.2% Nov 30, 2013 10-Q 2013-12-13
Q3 2013 66.9M +19.8M +42.1% Aug 31, 2013 10-Q 2013-09-13
Q2 2013 66.9M +19.8M +42% Jul 19, 2013 10-K 2013-07-26
Q1 2013 66.8M +19.7M +42% Feb 28, 2013 10-Q 2013-03-13
Q4 2012 47M +38.7K +0.08% Nov 30, 2012 10-Q 2012-12-13
Q3 2012 47M +769K +1.66% Aug 31, 2012 10-Q 2012-09-12
Q2 2012 47.1M Jul 6, 2012 10-K 2012-07-18
Q1 2012 47M Feb 29, 2012 10-Q 2012-03-14
Q4 2011 47M Nov 30, 2011 10-Q 2011-12-14
Q3 2011 46.3M Aug 31, 2011 10-Q 2011-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.